Babylon Biosciences
PrivateLast Round
Pre Seed
Oct 30, 2024
Momentum Score
50 /100
Company Overview
Babylon Biosciences is a biotechnology company developing small-molecule therapeutics for diseases of the brain, such as Alzheimer's.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Babylon Biosciences Comps
Public and private peers based on sector, stage, and business model.
Babylon Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 30, 2024 |
Babylon Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Backwards Capital | Pre Seed |
| Founders Fund | Pre Seed |
| Lux Capital | Pre Seed |
| Mission BioCapital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 207% MoM, reaching 3.2K.
Babylon Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Babylon Biosciences's valuation, stock price, and market status.
